DOCSLIB.ORG

Cytokine and Growth Factor Catalog

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Cytokine and Growth Factor Catalog Cytokines & Growth Factors Catalogue { 2017-2018) Sino Biological Biological Solution Specialist Index Advantages .................................................................. 1 Product List (by research areas) ................................ 2 Product List (by family) ................................................ 8 Product List (by molecule) .......................................... 14 Popular Factors (small package) .............................. 47 References (section) ................................................... 52 Advantages √ ISO9001 certifications Comparison Diagram of Bioactivity with different brands 1000 0 √ Apply to cell culture 50 1000 √ Rigorous QC 100 Relative ED Relative √ High purity (SDS-PAGE) (Normalization) 10 √ Low endotoxin level (LAL assay) 1 CSF3 aFGF bFGF HGFIIFN FNβIβ IFNFNγIγ IL21L21TTNFSF10 NFSF10 √ Carrier Free (no BSA) Sinobiological 10 10 10 10 10 10 10 10 LT 36 400992 25 50 04417 17 58 25 40 PT 1434400 00 42 508333 83332250 50 2084208 40 0 √ Animal Free for most reagents RD 10 16 58 50167 167115 51142 42 160 HZ 14 50 50 VEGF165, measured in a cell proliferation assay using HUVEC hESC cultured with TGF-β1+bFGF NGF, measured in a cell proliferation assay using TF-1 hESC hESC cultured with bFGF Sino Biological 01 Cytokines & Growth Factors (by research areas) AIDS / HIV CCL21 CCL5 IFNB1 IL15 IL3 CCL22 CSF3 IFNG IL16 OSM CCL3 CX3CL1 IL10 IL17A TNF CCL4 CXCL12 IL13 IL2 Allergy CCL5 IL10 IL12B IL4 IL8 CD40LG IL12A IL1B IL5 TNF CXCL10 IL12A & IL12B IL2 IL6 TNFSF8 IFNG Angiogenesis / Cardiovascular / Cardiogenesis ADIPOQ CXCL2 FGFBP3 IL12B OSM AIMP1 CXCL3 FIGF IL17A PDGFB ANGPT2 CXCL5 GDNF IL17F PDGFC ANGPT4 CXCL9 GREM1 IL18 PF4 ANGPTL1 EGF HBEGF IL1B PGF ANGPTL2 EGFL6 HGF IL24 PROK1 ANGPTL4 EGFL7 IFNA1 IL6 RETN ANGPTL5 EREG IFNA10 IL8 RSPO3 ANGPTL7 FGF1 IFNA13 INHBA SERPINA12 BMP2 FGF10 IFNA14 LEFTY2 SERPINF1 CCL13 FGF12 IFNA2 LEP TDGF1 CCL2 FGF14 IFNA4 LRIG1 TGFA CCL5 FGF16 IFNA5 LTA TGFB1 CCL7 FGF17 IFNA7 MDK TGFB2 CCL8 FGF18 IFNA8 MSTN TNF CD40LG FGF19 IFNG NAMPT TNFSF12 CNTF FGF2 IGF1 NGF TNFSF15 CSF3 FGF21 IL11 NOV TNFSF9 CX3CL1 FGF6 IL12A NRG1 VEGFA CXCL1 FGF7 IL12A & IL12B NRG4 VEGFC CXCL10 FGF9 02 Sino Biological Cytokines & Growth Factors (by research areas) Apoptosis ANGPT2 IGFBP3 IL21 LTA TNFSF10 BMP2 IGFBP4 IL24 NRG1 TNFSF11 CD40LG IGFBP5 IL4 SERPINF1 TNFSF12 CNTF IGFBP6 IL8 SHH TNFSF13 CX3CL1 IGFBP7 INHBA TGFB1 TNFSF13B HBEGF IL11 INHBB TGFB2 TNFSF9 IGFBP1 IL15 LEP TNF TSLP IGFBP2 IL16 LGALS1 Bone / Skeletal / Cartilage ANGPT2 CNTF IGF1 OSM SHH BMP2 DKK1 IL34 PDGFB TNFSF11 BMP5 FGF19 MSTN PDGFC WISP1 CCL14 Cancer CCL13 FIGF IL12A IL36B RSPO1 CCL2 FLT3LG IL12A & IL12B IL36G RSPO2 CCL7 HGF IL12B IL36RN RSPO3 CCL8 IFNB1 IL13 IL4 SCGB1A1 CSF1 IFNG IL15 IL6 SERPINF1 CSF2 IGFBP1 IL1A IL7 TGFA CSF3 IGFBP2 IL1B IL9 TGFB1 CX3CL1 IGFBP3 IL2 INHBA TGFB2 CXCL14 IGFBP4 IL21 LGALS1 TNF DKK1 IGFBP5 IL23A & IL12B NOV TNFSF13 EGF IGFBP6 IL24 NRG1 TNFSF8 EGFL7 IGFBP7 IL3 PDGFB VEGFA FGF1 IL10 IL34 PDGFC VEGFC FGF2 IL11 Cell Culture CSF2 FGF2 IL2 IL4 KITLG EGF FLT3LG IL3 IL6 THPO FGF1 IL15 Sino Biological 03 Cytokines & Growth Factors (by research areas) Chemotaxis CCL1 CCL21 CCL6 CXCL13 FAM19A2 CCL11 CCL22 CCL7 CXCL14 IL8 CCL13 CCL23 CCL8 CXCL16 MIF CCL14 CCL24 CX3CL1 CXCL2 NGF CCL15 CCL27 CXCL1 CXCL3 PF4 CCL16 CCL28 CXCL10 CXCL5 PPBP CCL17 CCL3 CXCL11 CXCL9 SCGB1A1 CCL18 CCL4 CXCL12 EGFL7 XCL1 CCL2 CCL5 CCL20 Diabetes / Weight Regulation CLCF1 IGFBP2 IL1A IL36RN NGF CNTF IGFBP3 IL1B IL6 RETN CSF3 IGFBP4 IL1RN LEP SERPINA12 IFNG IGFBP5 IL2 LIF TNF IGF1 IGFBP6 IL36B MSTN TNFSF8 IGFBP1 IGFBP7 IL36G Immune System CCL1 CD40LG IL11 IL22 LIF CCL11 CD70 IL12A IL23A & IL12B LTA CCL13 CLCF1 IL12A & IL12B IL25 OSM CCL17 CX3CL1 IL12B IL3 PDGFB CCL2 CXCL10 IL13 IL31 PDGFC CCL21 CXCL11 IL15 IL33 SHH CCL22 CXCL12 IL16 IL34 TGFB1 CCL24 CXCL13 IL17A IL36B TGFB2 CCL27 CXCL16 IL17F IL36G TNF CCL3 CXCL9 IL1A IL36RN TNFSF11 CCL4 FLT3LG IL1B IL4 TNFSF13 CCL5 IFNB1 IL2 IL5 TNFSF13B CCL6 IFNG IL20 IL6 TNFSF8 CCL7 IFNW1 IL21 LGALS1 TNFSF9 CCL8 IL10 04 Sino Biological Cytokines & Growth Factors (by research areas) Inflammation CCL2 CXCL16 IL11 IL36B PF4 CCL21 CXCL2 IL12A IL36G RETN CCL3 CXCL3 IL12A & IL12B IL36RN SCGB1A1 CCL4 CXCL5 IL12B IL4 SERPINA12 CCL5 CXCL9 IL13 IL5 TGFA CD40LG EGF IL15 IL6 TGFB1 CNTF EGFL7 IL1A IL7 TGFB2 CSF2 FGF2 IL1B IL8 TNF CSF3 FIGF IL1RN LEP TNFSF12 CX3CL1 GRN IL2 LTA TNFSF8 CXCL1 IFNA2 IL20 NGF VEGFA CXCL10 IGF1 IL23A & IL12B OSM VEGFC CXCL12 IL10 IL34 Markers ADIPOQ GDF10 LIF NAMPT TDGF1 EGFL6 IL37 LTA SCGB3A1 TMEFF1 FASLG LEFTY2 Neurobiology BDNF CLCF1 FGF1 IL1RN MANF BMP5 CNTF FGF2 IL2 NGF CCL1 CX3CL1 GDNF IL36B NTF3 CCL13 CXCL1 HGF IL36G PDGFB CCL2 CXCL10 IFNG IL36RN PDGFC CCL3 CXCL12 IL10 IL6 PRL CCL4 CXCL2 IL17B IL8 RSPO1 CCL5 CXCL3 IL18 INHBA TNF CCL7 DKK1 IL1A INHBB TNFSF12 CCL8 EGF IL1B LTA Sino Biological 05 Cytokines & Growth Factors (by research areas) Proliferation BDNF FGF10 FLT3LG IL3 NOV BMP2 FGF16 HBEGF IL34 NRG1 BTC FGF17 HGF IL36G PRL CD40LG FGF18 IGF1 IL36RN RSPO1 CSF1 FGF19 IL17F IL4 RSPO3 CSF2 FGF2 IL1A IL5 TGFB1 CXCL10 FGF21 IL1B KITLG TGFB2 EGF FGF6 IL2 LIF THPO EPO FGF7 IL20 LTA TNFSF12 FGF1 FGF9 Signaling Pathway FASLG GDF10 LEFTY2 LTB TDGF1 Stem Cells Differentiation BDNF FGF10 IL10 IL4 NRG1 BMP2 FGF19 IL12A IL6 PDGFB CNTF FGF2 IL12A & IL12B IL7 PDGFC CSF1 FGF7 IL12B INHBA PRL CSF2 FLT3LG IL13 INHBB TGFB1 CXCL12 GDF15 IL15 KITLG TGFB2 EGF GDNF IL1A LIF THPO EGFL7 HGF IL1B LTA TNF FGF1 IFNG IL2 NGF TNFSF13B Transplantation CCL3 IFNG IL12B IL1B IL6 CCL5 IL12A IL1A IL4 TNFSF9 CXCL10 IL12A & IL12B 06 Sino Biological Cytokines & Growth Factors (by research areas) Wound Healing CCL11 CCL5 CXCL14 IL1A IL8 CCL14 CCL6 CXCL2 IL1B LEP CCL17 CX3CL1 CXCL3 IL2 NGF CCL2 CXCL1 CXCL9 IL36G PDGFB CCL21 CXCL10 FGF10 IL36RN PDGFC CCL24 CXCL11 FGF2 IL5 TGFB1 CCL27 CXCL12 FGF7 IL6 TGFB2 CCL3 CXCL13 Other Areas ANGPT1 EFNB1 FAM3D IL19 Ppbp CDNF EFNB2 IFNL1 IL1F10 PTN CTF1 EFNB2A IFNL2 IL27 SCG2 EFNA1 EFNB3 IFNL3 IL32 TNFSF4 EFNA2 FAM19A4 IGF2BP2 IL35 VSTM1 EFNA3 FAM3B IL12A & IL27B IL36A VTN EFNA4 FAM3C IL18BP PDGFA XCL2 EFNA5 Cell therapy IL1A IL7 IFN-γ HGF bFGF IL2 IL-11 TNF-a NGF KGF IL-3 IL12 GM-CSF NT-3 FLT-3L IL4 IL15 M-CSF EGF SCF IL6 IL21 Sino Biological 07 Cytokines & Growth Factors (by family) Activin/Inhibin ACVR1 ACVR2A ACVRL1 FSTL1 INHBA ACVR1B ACVR2B FST FSTL3 INHBB Angiopoietin ANGPT1 ANGPT4 ANGPTL2 ANGPTL5 ANGPTL7 ANGPT2 ANGPTL1 ANGPTL4 Bone Morphogenetic Protein (BMP) & Receptor BAMBI BMP5 BMPR2 FSTL3 NOG BMP2 BMPR1A CER1 GDF10 SOST BMP4 BMPR1B FST NBL1 TMEFF1 Chemokine CCL1 CCL2 CCL4 CXCL11 CXCL8 CCL11 CCL20 CCL5 CXCL12 CXCL9 CCL12 CCL21 CCL6 CXCL13 FAM19A2 CCL13 CCL22 CCL7 CXCL14 FAM19A4 CCL14 CCL23 CCL8 CXCL16 PF4 CCL15 CCL24 CX3CL1 CXCL2 PPBP CCL16 CCL27 CXCL1 CXCL3 XCL1 CCL17 CCL28 CXCL10 CXCL5 XCL2 CCL18 CCL3 Colony-Stimulating Factor (CSF) & Receptor CSF1 CSF2 CSF2RB CSF3 CSF3R CSF1R CSF2RA Epidermal Growth Factor (EGF) & Receptor BTC EGFL7 ERBB3 HBEGF NRG4 EGF EGFR ERBB4 LRIG1 TGFA EGFL6 ERBB2 EREG NRG1 TMEFF1 08 Sino Biological Cytokines & Growth Factors (by family) Ephrin & Eph Receptor EFNA1 EFNA5 EFNB3 EPHA4 EPHB2 EFNA2 EFNB1 EPHA1 EPHA6 EPHB3 EFNA3 EFNB2 EPHA2 EPHA7 EPHB4 EFNA4 EFNB2A EPHA3 EPHB1 EPHB6 Fibroblast Growth Factor (FGF) & Receptor FGF1 FGF16 FGF2 FGF9 FGFR2 FGF10 FGF17 FGF21 FGFBP3 FGFR3 FGF12 FGF18 FGF6 FGFR1 FGFR4 FGF14 FGF19 FGF7 FGFR1OP FGFRL1 Fibroblast Growth Factor (FGF) & Receptor GDNF GFRA2 GFRA3 NCAM1 NCAM2 GFRA1 Growth Differentiation Factor (GDF) GDF10 GDF15 MSTN Hedgehog GPC3 SHH Hormones ADIPOQ ECE1 HGF NPY SCG2 ADM ECE2 HMGN3 PAM SCGB2A1 AKR1C2 ENPEP HSD17B14 PCSK1 SCGB3A1 ANGPT2 EPO IFNA8 PGLYRP1 SERPINA7 CALCA FST IFNL2 PRL SGMS2 CALCR FSTL3 INHBA PRLR STC1 CGA GDF15 INHBB PROK1 SULT1A1 CPE GFER LEP PTH SULT1B1 CPM GH1 LEPR PTH1R SULT2A1 CSH1 GHR MET PTMA TPO CTF1 GHRH MLN PTN VIP EBAG9 GIP NGF RAMP3 VIPR2 Sino Biological 09 Cytokines & Growth Factors (by family) Insulin-like Growth Factor (IGF) System IGF1 IGF2BP2 IGFBP3 IGFBP6 INSR IGF1R IGFBP1 IGFBP4 IGFBP7 NOV IGF2 IGFBP2 IGFBP5 IGFLR1 WISP1 IL-1 Family & Receptor IL18 IL1R1 IL1RN IL37 MAPK8 IL18BP IL1R2 IL33 MAP2K4 MAPK9 IL18R1 IL1RAP IL36A MAP2K6 MARK3 IL18RAP IL1RAPL1 IL36B MAPK1 NFKBIA IL1A IL1RAPL2 IL36G MAPK13 RELA IL1B IL1RL1 IL36RN MAPK14 SIGIRR IL1F10 IL1RL2 IL-10 Family & Receptor IFNL1 IL10RB IL20RA IL22RA1 STAT1 IFNL3 IL19 IL20RB IL22RA2 STAT4 IL10 IL20 IL22 IL24 STAT6 IL10RA IL-12 Family & Receptor IL12A IL12B IL23 IL27 IL35 IL12A & IL12B IL12RB1 IL23R IL27RA IL6ST IL12A & IL27B IL12RB2 IL-17 Family & Receptor IL17A IL17RA IL17RD MAPK13 NFKBIA IL17B IL17RB IL25 MAPK14 RELA IL17F IL17RC MAPK1 IL-6 Family & Receptor CLCF1 CSF2RA IL11RA IL6 LIFR CNTF CSF3 IL11RA1 IL6R OSM CNTFR CSF3R IL31 IL6ST OSMR CSF2 IL11 IL31RA LIF 10 Sino Biological Cytokines & Growth Factors (by family) Other Interleukin & Receptor CSF2RB IL15 IL2RA IL34 IL5RA CXCL8 IL16 IL2RB IL3RA IL7 IL13 IL2 IL2RG IL4 IL7R IL13RA1 IL21 IL3 IL4R IL9 IL13RA2 IL21R IL32 IL5 IL9R Interferon & Receptor IFNA1 IFNA2 IFNAR1 IFNG IFNL1 IFNA10 IFNA4 IFNAR2 IFNGR1 IFNL3 IFNA13 IFNA5 IFNB1 IFNGR2 IFNW1 IFNA14 IFNA7 Neurotrophin & Receptor BDNF MANF NTF3 NTRK2 NTRK3 CDNF NGFR NTRK1 Other Growth Factors & Receptors DKK1 KITLG MDK TDGF1 THPO EPOR LGALS1 SERPINF1 Other Cytokines & Receptors ADIPOQ FLRT3 MIF RETN SERPINA12 AIMP1 FLT3LG MPL SCG2 TSLP FAM3B GREM1 NAMPT SCGB1A1 VSTM1 FAM3C GRN RARRES2 SCGB3A1 VTN FAM3D Platelet-Derived Growth Factor (PDGF) & Receptor PDGFA PDGFB PDGFC PDGFRA PDGFRB Sino Biological 11 Cytokines & Growth Factors (by family) Proteoglycans AMBP EPYC OMD SDC2 SPOCK1 BGN ESM1 PRELP SDC3
Load more

Recommended publications
  • Fgf17b and FGF18 Have Different Midbrain Regulatory Properties from Fgf8b Or Activated FGF Receptors Aimin Liu1,2, James Y
    Research article 6175 FGF17b and FGF18 have different midbrain regulatory properties from FGF8b or activated FGF receptors Aimin Liu1,2, James Y. H. Li2, Carrie Bromleigh2, Zhimin Lao2, Lee A. Niswander1 and Alexandra L. Joyner2,* 1Howard Hughes Medical Institute, Developmental Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA 2Howard Hughes Medical Institute and Skirball Institute of Biomolecular Medicine, Departments of Cell Biology, and Physiology and Neuroscience, NYU School of Medicine, New York, NY 10016, USA *Author for correspondence (e-mail: [email protected]) Accepted 28 August 2003 Development 130, 6175-6185 Published by The Company of Biologists 2003 doi:10.1242/dev.00845 Summary Early patterning of the vertebrate midbrain and region in the midbrain, correlating with cerebellum cerebellum is regulated by a mid/hindbrain organizer that development. By contrast, FGF17b and FGF18 mimic produces three fibroblast growth factors (FGF8, FGF17 FGF8a by causing expansion of the midbrain and and FGF18). The mechanism by which each FGF upregulating midbrain gene expression. This result is contributes to patterning the midbrain, and induces a consistent with Fgf17 and Fgf18 being expressed in the cerebellum in rhombomere 1 (r1) is not clear. We and midbrain and not just in r1 as Fgf8 is. Third, analysis of others have found that FGF8b can transform the midbrain gene expression in mouse brain explants with beads soaked into a cerebellum fate, whereas FGF8a can promote in FGF8b or FGF17b showed that the distinct activities of midbrain development. In this study we used a chick FGF17b and FGF8b are not due to differences in the electroporation assay and in vitro mouse brain explant amount of FGF17b protein produced in vivo.
    [Show full text]
  • The TNF and TNF Receptor Review Superfamilies: Integrating Mammalian Biology
    Cell, Vol. 104, 487±501, February 23, 2001, Copyright 2001 by Cell Press The TNF and TNF Receptor Review Superfamilies: Integrating Mammalian Biology Richard M. Locksley,*²³k Nigel Killeen,²k The receptors and ligands in this superfamily have and Michael J. Lenardo§k unique structural attributes that couple them directly to *Department of Medicine signaling pathways for cell proliferation, survival, and ² Department of Microbiology and Immunology differentiation. Thus, they have assumed prominent ³ Howard Hughes Medical Institute roles in the generation of tissues and transient microen- University of California, San Francisco vironments. Most TNF/TNFR SFPs are expressed in the San Francisco, California 94143 immune system, where their rapid and potent signaling § Laboratory of Immunology capabilities are crucial in coordinating the proliferation National Institute of Allergy and Infectious Diseases and protective functions of pathogen-reactive cells. National Institutes of Health Here, we review the organization of the TNF/TNFR SF Bethesda, Maryland 20892 and how these proteins have been adapted for pro- cesses as seemingly disparate as host defense and or- ganogenesis. In interpreting this large and highly active Introduction area of research, we have focused on common themes that unite the actions of these genes in different tissues. Three decades ago, lymphotoxin (LT) and tumor necro- We also discuss the evolutionary success of this super- sis factor (TNF) were identified as products of lympho- familyÐsuccess that we infer from its expansion across cytes and macrophages that caused the lysis of certain the mammalian genome and from its many indispens- types of cells, especially tumor cells (Granger et al., able roles in mammalian biology.
    [Show full text]
  • Supplemental Figure 1. Vimentin
    Double mutant specific genes Transcript gene_assignment Gene Symbol RefSeq FDR Fold- FDR Fold- FDR Fold- ID (single vs. Change (double Change (double Change wt) (single vs. wt) (double vs. single) (double vs. wt) vs. wt) vs. single) 10485013 BC085239 // 1110051M20Rik // RIKEN cDNA 1110051M20 gene // 2 E1 // 228356 /// NM 1110051M20Ri BC085239 0.164013 -1.38517 0.0345128 -2.24228 0.154535 -1.61877 k 10358717 NM_197990 // 1700025G04Rik // RIKEN cDNA 1700025G04 gene // 1 G2 // 69399 /// BC 1700025G04Rik NM_197990 0.142593 -1.37878 0.0212926 -3.13385 0.093068 -2.27291 10358713 NM_197990 // 1700025G04Rik // RIKEN cDNA 1700025G04 gene // 1 G2 // 69399 1700025G04Rik NM_197990 0.0655213 -1.71563 0.0222468 -2.32498 0.166843 -1.35517 10481312 NM_027283 // 1700026L06Rik // RIKEN cDNA 1700026L06 gene // 2 A3 // 69987 /// EN 1700026L06Rik NM_027283 0.0503754 -1.46385 0.0140999 -2.19537 0.0825609 -1.49972 10351465 BC150846 // 1700084C01Rik // RIKEN cDNA 1700084C01 gene // 1 H3 // 78465 /// NM_ 1700084C01Rik BC150846 0.107391 -1.5916 0.0385418 -2.05801 0.295457 -1.29305 10569654 AK007416 // 1810010D01Rik // RIKEN cDNA 1810010D01 gene // 7 F5 // 381935 /// XR 1810010D01Rik AK007416 0.145576 1.69432 0.0476957 2.51662 0.288571 1.48533 10508883 NM_001083916 // 1810019J16Rik // RIKEN cDNA 1810019J16 gene // 4 D2.3 // 69073 / 1810019J16Rik NM_001083916 0.0533206 1.57139 0.0145433 2.56417 0.0836674 1.63179 10585282 ENSMUST00000050829 // 2010007H06Rik // RIKEN cDNA 2010007H06 gene // --- // 6984 2010007H06Rik ENSMUST00000050829 0.129914 -1.71998 0.0434862 -2.51672
    [Show full text]
  • IL17RB Antibody Cat
    IL17RB Antibody Cat. No.: 62-448 IL17RB Antibody Formalin-fixed and paraffin-embedded human colon Flow cytometric analysis of HepG2 cells using IL17RB carcinoma reacted with IL17RB Antibody , which was Antibody (bottom histogram) compared to a negative peroxidase-conjugated to the secondary antibody, control cell (top histogram). FITC-conjugated goat-anti- followed by DAB staining. rabbit secondary antibodies were used for the analysis. Specifications HOST SPECIES: Rabbit SPECIES REACTIVITY: Human This IL17_ antibody is generated from rabbits immunized with a KLH conjugated synthetic IMMUNOGEN: peptide between 207-234 amino acids from the Central region of human IL17_. TESTED APPLICATIONS: Flow, IHC-P, WB For WB starting dilution is: 1:1000 APPLICATIONS: For IHC-P starting dilution is: 1:10~50 For FACS starting dilution is: 1:10~50 September 25, 2021 1 https://www.prosci-inc.com/il17rb-antibody-62-448.html PREDICTED MOLECULAR 56 kDa WEIGHT: Properties This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by PURIFICATION: dialysis CLONALITY: Polyclonal ISOTYPE: Rabbit Ig CONJUGATE: Unconjugated PHYSICAL STATE: Liquid BUFFER: Supplied in PBS with 0.09% (W/V) sodium azide. CONCENTRATION: batch dependent Store at 4˚C for three months and -20˚C, stable for up to one year. As with all antibodies STORAGE CONDITIONS: care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures. Additional Info OFFICIAL SYMBOL: IL17RB Interleukin-17 receptor B, IL-17 receptor B, IL-17RB, Cytokine receptor-like 4, IL-17 ALTERNATE NAMES: receptor homolog 1, IL-17Rh1, IL17Rh1, Interleukin-17B receptor, IL-17B receptor, IL17RB, CRL4, EVI27, IL17BR ACCESSION NO.: Q9NRM6 PROTEIN GI NO.: 21263748 GENE ID: 55540 USER NOTE: Optimal dilutions for each application to be determined by the researcher.
    [Show full text]
  • ARTICLES Fibroblast Growth Factors 1, 2, 17, and 19 Are The
    0031-3998/07/6103-0267 PEDIATRIC RESEARCH Vol. 61, No. 3, 2007 Copyright © 2007 International Pediatric Research Foundation, Inc. Printed in U.S.A. ARTICLES Fibroblast Growth Factors 1, 2, 17, and 19 Are the Predominant FGF Ligands Expressed in Human Fetal Growth Plate Cartilage PAVEL KREJCI, DEBORAH KRAKOW, PERTCHOUI B. MEKIKIAN, AND WILLIAM R. WILCOX Medical Genetics Institute [P.K., D.K., P.B.M., W.R.W.], Cedars-Sinai Medical Center, Los Angeles, California 90048; Department of Obstetrics and Gynecology [D.K.] and Department of Pediatrics [W.R.W.], UCLA School of Medicine, Los Angeles, California 90095 ABSTRACT: Fibroblast growth factors (FGF) regulate bone growth, (G380R) or TD (K650E) mutations (4–6). When expressed at but their expression in human cartilage is unclear. Here, we deter- physiologic levels, FGFR3-G380R required, like its wild-type mined the expression of entire FGF family in human fetal growth counterpart, ligand for activation (7). Similarly, in vitro cul- plate cartilage. Using reverse transcriptase PCR, the transcripts for tivated human TD chondrocytes as well as chondrocytes FGF1, 2, 5, 8–14, 16–19, and 21 were found. However, only FGF1, isolated from Fgfr3-K644M mice had an identical time course 2, 17, and 19 were detectable at the protein level. By immunohisto- of Fgfr3 activation compared with wild-type chondrocytes and chemistry, FGF17 and 19 were uniformly expressed within the showed no receptor activation in the absence of ligand (8,9). growth plate. In contrast, FGF1 was found only in proliferating and hypertrophic chondrocytes whereas FGF2 localized predominantly to Despite the importance of the FGF ligand for activation of the resting and proliferating cartilage.
    [Show full text]
  • Cytokine Nomenclature
    RayBiotech, Inc. The protein array pioneer company Cytokine Nomenclature Cytokine Name Official Full Name Genbank Related Names Symbol 4-1BB TNFRSF Tumor necrosis factor NP_001552 CD137, ILA, 4-1BB ligand receptor 9 receptor superfamily .2. member 9 6Ckine CCL21 6-Cysteine Chemokine NM_002989 Small-inducible cytokine A21, Beta chemokine exodus-2, Secondary lymphoid-tissue chemokine, SLC, SCYA21 ACE ACE Angiotensin-converting NP_000780 CD143, DCP, DCP1 enzyme .1. NP_690043 .1. ACE-2 ACE2 Angiotensin-converting NP_068576 ACE-related carboxypeptidase, enzyme 2 .1 Angiotensin-converting enzyme homolog ACTH ACTH Adrenocorticotropic NP_000930 POMC, Pro-opiomelanocortin, hormone .1. Corticotropin-lipotropin, NPP, NP_001030 Melanotropin gamma, Gamma- 333.1 MSH, Potential peptide, Corticotropin, Melanotropin alpha, Alpha-MSH, Corticotropin-like intermediary peptide, CLIP, Lipotropin beta, Beta-LPH, Lipotropin gamma, Gamma-LPH, Melanotropin beta, Beta-MSH, Beta-endorphin, Met-enkephalin ACTHR ACTHR Adrenocorticotropic NP_000520 Melanocortin receptor 2, MC2-R hormone receptor .1 Activin A INHBA Activin A NM_002192 Activin beta-A chain, Erythroid differentiation protein, EDF, INHBA Activin B INHBB Activin B NM_002193 Inhibin beta B chain, Activin beta-B chain Activin C INHBC Activin C NM005538 Inhibin, beta C Activin RIA ACVR1 Activin receptor type-1 NM_001105 Activin receptor type I, ACTR-I, Serine/threonine-protein kinase receptor R1, SKR1, Activin receptor-like kinase 2, ALK-2, TGF-B superfamily receptor type I, TSR-I, ACVRLK2 Activin RIB ACVR1B
    [Show full text]
  • FGF14 Regulates Presynaptic Ca2+ Channels and Synaptic Transmission
    Cell Reports Article FGF14 Regulates Presynaptic Ca2+ Channels and Synaptic Transmission Haidun Yan,1,3 Juan L. Pablo,2,3 and Geoffrey S. Pitt1,2,3,* 1Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA 2Department of Neurobiology, Duke University Medical Center, Durham, NC 27710, USA 3Ion Channel Research Unit, Duke University Medical Center, Durham, NC 27710, USA *Correspondence: [email protected] http://dx.doi.org/10.1016/j.celrep.2013.06.012 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited. SUMMARY data pinpointed FGF14 as the locus for spinocerebellar ataxia 27 (SCA27). Fibroblast growth factor homologous factors (FHFs) Focus on FHF regulation of neuronal excitability began when are not growth factors, but instead bind to voltage- Fgf14–/– mice showed ataxia (Wang et al., 2002), providing + gated Na channels (NaV) and regulate their function. a basis for exploring the implications of a linkage analysis that Mutations in FGF14, an FHF that is the locus for identified a F150S missense mutation in a ‘‘b’’ splice variant of F150S F145S spinocerebellar ataxia 27 (SCA27), are believed to FGF14 (FGF14b ; termed FGF14 in some studies that be pathogenic because of a dominant-negative used numbering based on the alternatively spliced FGF14a variant) as the etiology of the autosomal-dominant SCA27 in reduction of Na currents in cerebellar granule cells. V an extended Dutch family (van Swieten et al., 2003).
    [Show full text]
  • Role and Regulation of Pdgfra Signaling in Liver Development and Regeneration
    The American Journal of Pathology, Vol. 182, No. 5, May 2013 ajp.amjpathol.org GROWTH FACTORS, CYTOKINES, AND CELL CYCLE MOLECULES Role and Regulation of PDGFRa Signaling in Liver Development and Regeneration Prince K. Awuah,* Kari N. Nejak-Bowen,* and Satdarshan P.S. Monga*y From the Division of Experimental Pathology,* Department of Pathology, and the Department of Medicine,y University of Pittsburgh, Pittsburgh, Pennsylvania Accepted for publication January 22, 2013. Aberrant platelet-derived growth factor receptor-a (PDGFRa) signaling is evident in a subset of hepato- cellular cancers (HCCs). However, its role and regulation in hepatic physiology remains elusive. In the Address correspondence to a fi Satdarshan P.S. Monga, M.D., current study, we examined PDGFR signaling in liver development and regeneration. We identi ed a a Divisions of Experimental notable PDGFR activation in hepatic morphogenesis that, when interrupted by PDGFR -blocking anti- Pathology, Pathology and body, led to decreased hepatoblast proliferation and survival in embryonic liver cultures. We also identified Medicine, University of Pitts- temporal PDGFRa overexpression, which is regulated by epidermal growth factor (EGF) and tumor necrosis burgh School of Medicine, 200 factor a, and its activation at 3 to 24 hours after partial hepatectomy. Through generation of hepatocyte- Lothrop St., S-422 BST, Pitts- specific PDGFRA knockout (KO) mice that lack an overt phenotype, we show that absent PDGFRa burgh, PA 15261. E-mail: compromises extracelluar signal-regulated kinases and AKT activation 3 hours after partial hepatectomy, [email protected]. which, however, is alleviated by temporal compensatory increases in the EGF receptor (EGFR) and the hepatocyte growth factor receptor (Met) expression and activation along with rebound activation of extracellular signal-regulated kinases and AKT at 24 hours.
    [Show full text]
  • IL-12 Abrogates Calcineurin-Dependent Immune Evasion During Leukemia Progression
    Author Manuscript Published OnlineFirst on May 29, 2019; DOI: 10.1158/0008-5472.CAN-18-3800 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. IL-12 abrogates calcineurin-dependent immune evasion during leukemia progression Jennifer L. Rabe,1* Lori Gardner,2* Rae Hunter,3 Jairo A. Fonseca,3 Jodi Dougan,3 Christy M. Gearheart,2 Michael S. Leibowitz,2 Cathy Lee-Miller,2 Dmitry Baturin,2 Susan P. Fosmire,2 Susan E. Zelasko,2 Courtney L. Jones,2 Jill E. Slansky,4 Manali Rupji,5 Bhakti Dwivedi,5 Curtis J. Henry,3,5,6 and Christopher C. Porter3,5,6 Affiliations: 1Molecular Biology Program, University of Colorado Denver, Aurora, CO. 2Department of Pediatrics, University of Colorado, Aurora, CO 3Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 4Integrated Department of Immunology, University of Colorado School of Medicine, Aurora, CO 5Winship Cancer Institute, Emory University, Atlanta, GA 6Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta, GA JR and LAG contributed equally to this study. Corresponding Author: Christopher C. Porter, MD Emory University School of Medicine 1760 Haygood Drive, E370 Atlanta, GA 30322 Phone: 404-727-4881 Fax: 404-727-4455 [email protected] Running title: Leukemia-cell calcineurin drives immune evasion Conflict of interest statement The authors have declared that no conflicts of interest exist. Abstract: 199 words Main Text: 5797 words (excluding figure legends and references) Downloaded from cancerres.aacrjournals.org on October 2, 2021. © 2019 American Association for Cancer Research. Author Manuscript Published OnlineFirst on May 29, 2019; DOI: 10.1158/0008-5472.CAN-18-3800 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
    [Show full text]
  • Fibroblast Growth Factor 12 Is Expressed in Spiral and Vestibular
    www.nature.com/scientificreports OPEN Fibroblast growth factor 12 is expressed in spiral and vestibular ganglia and necessary for auditory Received: 5 February 2018 Accepted: 26 June 2018 and equilibrium function Published: xx xx xxxx Yukiko Hanada1,2, Yukiko Nakamura1, Yoshiyuki Ozono2, Yusuke Ishida1,3, Yasumitsu Takimoto1,2,4, Manabu Taniguchi5, Kazuya Ohata1,2, Yoshihisa Koyama1, Takao Imai2, Tetsuo Morihana2,6, Makoto Kondo1, Takashi Sato2, Hidenori Inohara2 & Shoichi Shimada1 We investigated fbroblast growth factor 12 (FGF12) as a transcript enriched in the inner ear by searching published cDNA library databases. FGF12 is a fbroblast growth factor homologous factor, a subset of the FGF superfamily. To date, its localisation and function in the inner ear have not been determined. Here, we show that FGF12 mRNA is localised in spiral ganglion neurons (SGNs) and the vestibular ganglion. We also show that FGF12 protein is localised in SGNs, the vestibular ganglion, and nerve fbres extending beneath hair cells. Moreover, we investigated FGF12 function in auditory and vestibular systems using Fgf12-knockout (FGF12-KO) mice generated with CRISPR/Cas9 technology. Our results show that the inner ear morphology of FGF12-KO mice is not signifcantly diferent compared with wild-type mice. However, FGF12-KO mice exhibited an increased hearing threshold, as measured by the auditory brainstem response, as well as defcits in rotarod and balance beam performance tests. These results suggest that FGF12 is necessary for normal auditory and equilibrium function. Hearing loss is a common problem in people of all ages. Te World Health Organization reports that 360 million people worldwide have hearing loss, with 32 million being children1.
    [Show full text]
  • Human IL12A / NKSF1 Protein (His Tag)
    Human IL12A / NKSF1 Protein (His Tag) Catalog Number: 10021-H08H General Information SDS-PAGE: Gene Name Synonym: CLMF; IL-12A; NFSK; NKSF1; P35 Protein Construction: A DNA sequence encoding the p35 subunit of human IL12, termed as IL12A (P29459) (Met 1-Ser 219) was expressed, fused with a polyhistidine tag at the C-terminus. Source: Human Expression Host: HEK293 Cells QC Testing Purity: > 92 % as determined by SDS-PAGE Bio Activity： Protein Description Measured by its ability to bind Human IL12B-his in functional ELISA. Interleukin-12 subunit alpha (IL12A/IL-12p35) is also known as Cytotoxic lymphocyte maturation factor 35 kDa subunit, cytotoxic lymphocyte Endotoxin: maturation factor 1, p35, NK cell stimulatory factor chain 1, and interleukin- 12 alpha chain. IL12A/IL-12p35 is a subunit of a cytokine that acts on T < 1.0 EU per μg of the protein as determined by the LAL method and natural killer cells, and has a broad array of biological activities. The cytokine is a disulfide-linked heterodimer composed of the 35-kD subunit Stability: encoded by this gene, and a 40-kD subunit that is a member of the Samples are stable for up to twelve months from date of receipt at -70 ℃ cytokine receptor family. IL12A/IL-12p35 is required for the T-cell- independent induction of IFN-gamma, and is important for the Predicted N terminal: Arg 23 differentiation of both Th1 and Th2 cells. The responses of lymphocytes to this cytokine are mediated by the activator of transcription protein STAT4. Molecular Mass: Nitric oxide synthase 2A (NOS2A/NOS2) is found to be required for the signaling process of this cytokine in innate immunity.
    [Show full text]
  • Single-Cell RNA Sequencing Demonstrates the Molecular and Cellular Reprogramming of Metastatic Lung Adenocarcinoma
    ARTICLE https://doi.org/10.1038/s41467-020-16164-1 OPEN Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma Nayoung Kim 1,2,3,13, Hong Kwan Kim4,13, Kyungjong Lee 5,13, Yourae Hong 1,6, Jong Ho Cho4, Jung Won Choi7, Jung-Il Lee7, Yeon-Lim Suh8,BoMiKu9, Hye Hyeon Eum 1,2,3, Soyean Choi 1, Yoon-La Choi6,10,11, Je-Gun Joung1, Woong-Yang Park 1,2,6, Hyun Ae Jung12, Jong-Mu Sun12, Se-Hoon Lee12, ✉ ✉ Jin Seok Ahn12, Keunchil Park12, Myung-Ju Ahn 12 & Hae-Ock Lee 1,2,3,6 1234567890():,; Advanced metastatic cancer poses utmost clinical challenges and may present molecular and cellular features distinct from an early-stage cancer. Herein, we present single-cell tran- scriptome profiling of metastatic lung adenocarcinoma, the most prevalent histological lung cancer type diagnosed at stage IV in over 40% of all cases. From 208,506 cells populating the normal tissues or early to metastatic stage cancer in 44 patients, we identify a cancer cell subtype deviating from the normal differentiation trajectory and dominating the metastatic stage. In all stages, the stromal and immune cell dynamics reveal ontological and functional changes that create a pro-tumoral and immunosuppressive microenvironment. Normal resident myeloid cell populations are gradually replaced with monocyte-derived macrophages and dendritic cells, along with T-cell exhaustion. This extensive single-cell analysis enhances our understanding of molecular and cellular dynamics in metastatic lung cancer and reveals potential diagnostic and therapeutic targets in cancer-microenvironment interactions. 1 Samsung Genome Institute, Samsung Medical Center, Seoul 06351, Korea.
    [Show full text]